DFO
NRIX icon

Duquesne Family Office’s Nurix Therapeutics NRIX Stock Holding History

Duquesne Family Office’s Portfolio NRIX Stock Details NRIX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-44,200
Closed -$993K – 88
2024
Q3 		$993K Hold
44,200
– – 0.03% 70
2024
Q2 		$922K Hold
44,200
– – 0.03% 61
2024
Q1 		$650K Buy
+44,200
New +$650K 0.01% 70